Further re Grant Application
28 Abril 2010 - 6:43AM
UK Regulatory
TIDMHML
RNS Number : 9394K
Henderson Morley PLC
28 April 2010
28 April 2010
HENDERSON MORLEY PLC
(AIM: HML)
FURTHER RE GRANT APPLICATION
The Board of Henderson Morley plc ("Henderson Morley"), the AIM quoted
biotechnology company, announces that, following its application for Grant
Funding from the Queensland Government funded Research Industry Partnership
Programme ("RIPP") as announced on 5 November 2009, it has been notified by the
Queensland Institute of Medical Research ("QIMR") that the application has been
unsuccessful, even though it was short listed.
The Cytomegalovirus Vaccine funding was not granted due to a shortage of funds
within RIPP despite having been recommended to the Minister of Health.
Commenting, Andrew Knight, Henderson Morley's Executive Chairman, said "We
continue to make applications for Grant funding both in the UK and Overseas and
whilst we are disappointed not to have been successful on this occasion, we
remain optimistic that we will receive Grant Funding in the future."
-END-
Enquires
HENDERSON MORLEY PLC
0121 442 4600
Andrew Knight, Chairman
BISHOPSGATECOMMUNICATIONS LTD 0207 562
3350
Maxine Barnes
Gemma O'Hara
BREWIN DOLPHIN INVESTMENT BANKING 0113 241
0126
Neil Baldwin
RIVINGTON STREET CORPORATE FINANCE 0207 562 3380
Leo Godsall
Further information on Henderson Morley plc can be accessed through the
Company's website at www.henderson-morley.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
FURPGUPCCUPUUBR
Henderson Mrly. (LSE:HML)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Henderson Mrly. (LSE:HML)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Henderson Mrly. da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Henderson Morley